PATENT CLAIM ANALYSIS

Application Number: 16142171
Application Type: Utility
Filing Date: 2018-09
Publication Date: 2019-01
Patent Classification: ["424", "190100"]

Abstract:
A system and method for reducing the likelihood of colorectal cancer in a human being includes the modification of an individual's gut microbes by employing a Clustered Regularly Interspaced Short Palindromic Repeats-CRISPR-associated system (CRISPR-Cas) or Clustered Regularly Interspaced Short Palindromic Repeats from  Prevotella  and  Francisella  1 (CRISPR/Cpf1) system to modify only bacterial genes of bacteria that reside in the human gut that are non-homologous to those encompassed in the human genome, and in particular, to administer a therapeutically effective amount of a bacterial formulation comprising  F. prausnitzii  that has been modified to produce one of alliin or butyrate.

Claim (Index 8):
The method of  claim 1 , wherein the  F. prausnitzii  bacterial population is administered to an individual in preferred ratios that reflect those of healthy individuals so as to attain the general balance of said bacterial population in the individual human being's gut.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 97.0
- Lexical Diversity: 1.49296
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15395419', '15392173', '16028311', '15820296', '15228454']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7393795001781184
- 35 USC 102 Novelty (BERT): 0.5861144239113191
- Combined Prediction Score: 0.7240529925514385
- Mean Citation Score: 349.762526
- Max Citation Score: 549.6457
- Similarity Product: 376.8721044081211

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test